Will ultrasound-screening and ultrasound-guided procedures be replaced by non-invasive techniques for the diagnosis of fetal chromosome anomalies?

被引:27
作者
Holzgreve, W
机构
关键词
D O I
10.1046/j.1469-0705.1997.09040217.x
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
引用
收藏
页码:217 / 219
页数:3
相关论文
共 17 条
[11]   PRENATAL KARYOTYPING - WHEN, HOW AND WHOM [J].
HOLZGREVE, W ;
TERCANLI, S ;
SCHNEIDER, HPG ;
MINY, P .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1992, 2 (01) :64-69
[12]  
PANDYA PP, 1994, OBSTET GYNECOL, V84, P420
[13]   ISOLATING FETAL CELLS FROM MATERNAL BLOOD - ADVANCES IN PRENATAL-DIAGNOSIS THROUGH MOLECULAR TECHNOLOGY [J].
SIMPSON, JL ;
ELIAS, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (19) :2357-2361
[14]  
SNIJDERS RJM, 1996, ULTRASOUND MARKERS F
[15]  
TABOR A, 1986, LANCET, V1, P1287
[16]   Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy [J].
Wald, NJ ;
George, L ;
Smith, D ;
Densem, JW ;
Petterson, K .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (05) :407-412
[17]  
1990, LANCET, V336, P87